Impact of vaccination and immune response in reducing Hepatitis B-related liver disease model
Thangavel Megala , Nandha Gopal , Mehmet Yavuz , Muthurathinam Sivabalan , Manickasundaram Siva Pradeep
Networks and Heterogeneous Media ›› 2026, Vol. 21 ›› Issue (5) : 1987 -2006.
Hepatitis B virus (HBV) infection can progress from acute infection to chronic liver disease, posing a major public health concern. In this work, a mathematical model incorporating immune response and vaccination is developed using susceptible, infected, chronic, and recovered populations. Positivity and boundedness of solutions are established, and disease-free and endemic equilibria are analyzed. The basic reproduction numbers and stability conditions are derived using the next-generation matrix and Jacobian methods. Critical thresholds are obtained as $\Upsilon^{*}$ = 0.2237 for immune response and Γ* = 0.7466 for vaccination. Numerical simulations using the fourth-order Runge–Kutta method demonstrate that enhanced immune response and vaccination can reduce HBV infection and chronic cases. The findings provide quantitative evidence on the role of immune response and vaccination in controlling HBV transmission and disease progression.
vaccination / disease progression / liver disease / chronic infection
| [1] |
World Health Organization, Global Health Sector Strategies on, respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the period 2022-2030, World Health Organization, 2022. |
| [2] |
|
| [3] |
|
| [4] |
World Health Organization, Hepatitis B vaccines: WHO position paper-July 2017, Weekly Epidemiological Record, 92(2017), 369-392. |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
World Health Organization, Hepatitis B vaccines: WHO position paper, July 2017- Recommendations, Vaccine, 37(2019), 223-225. https://doi.org/10.1016/j.vaccine.2017.07.046 |
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
/
| 〈 |
|
〉 |